|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 29720 |
FusionGeneSummary for PVT1_EFNA1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: PVT1_EFNA1 | Fusion gene ID: 29720 | Hgene | Tgene | Gene symbol | PVT1 | EFNA1 | Gene ID | 5820 | 1942 |
| Gene name | Pvt1 oncogene | ephrin A1 | |
| Synonyms | LINC00079|MIR1204HG|MYC|NCRNA00079|onco-lncRNA-100 | B61|ECKLG|EFL1|EPLG1|LERK-1|LERK1|TNFAIP4 | |
| Cytomap | 8q24.21 | 1q22 | |
| Type of gene | ncRNA | protein-coding | |
| Description | CXCR4/PVT1 fusionHIST1H2BD/PVT1 fusionMIR1204, MIR1205, MIR1206 and MIR1207 hostOncogene PVT-1 (MYC activator)PVT1/CASC8 fusionPVT1/CCDC26 fusionPVT1/IFRD1 fusionPVT1/IRF2BP2 fusionPVT1/LINC00824 fusionPVT1/MYC fusionPVT1/NFIL3 fusionPVT1/NSMCE | ephrin-A1TNF alpha-induced protein 4eph-related receptor tyrosine kinase ligand 1immediate early response protein B61ligand of eph-related kinase 1tumor necrosis factor, alpha-induced protein 4 | |
| Modification date | 20180520 | 20180523 | |
| UniProtAcc | P20827 | ||
| Ensembl transtripts involved in fusion gene | ENST00000408388, | ENST00000368407, ENST00000368406, ENST00000469878, | |
| Fusion gene scores | * DoF score | 37 X 12 X 15=6660 | 1 X 1 X 1=1 |
| # samples | 39 | 1 | |
| ** MAII score | log2(39/6660*10)=-4.09397614820901 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(1/1*10)=3.32192809488736 | |
| Context | PubMed: PVT1 [Title/Abstract] AND EFNA1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | EFNA1 | GO:0016477 | cell migration | 10655584 |
| Tgene | EFNA1 | GO:0033628 | regulation of cell adhesion mediated by integrin | 10655584 |
| Tgene | EFNA1 | GO:0034446 | substrate adhesion-dependent cell spreading | 10655584 |
| Tgene | EFNA1 | GO:0048013 | ephrin receptor signaling pathway | 10655584 |
| Tgene | EFNA1 | GO:0050731 | positive regulation of peptidyl-tyrosine phosphorylation | 10655584 |
| Tgene | EFNA1 | GO:1902004 | positive regulation of amyloid-beta formation | 24217950 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | BLCA | TCGA-GV-A40E-01A | PVT1 | chr8 | 128903244 | + | EFNA1 | chr1 | 155103815 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3CDS | ENST00000408388 | ENST00000368407 | PVT1 | chr8 | 128903244 | + | EFNA1 | chr1 | 155103815 | + |
| intron-3CDS | ENST00000408388 | ENST00000368406 | PVT1 | chr8 | 128903244 | + | EFNA1 | chr1 | 155103815 | + |
| intron-3UTR | ENST00000408388 | ENST00000469878 | PVT1 | chr8 | 128903244 | + | EFNA1 | chr1 | 155103815 | + |
Top |
FusionProtFeatures for PVT1_EFNA1 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| PVT1 | EFNA1 |
| Lectin that binds to various sugars: galactose > mannose= fucose > N-acetylglucosamine > N-acetylgalactosamine(PubMed:10224141). Acts as a chemoattractant, probably involved inthe regulation of cell migration (PubMed:28301481).{ECO:0000269|PubMed:10224141, ECO:0000269|PubMed:28301481}. | Cell surface GPI-bound ligand for Eph receptors, afamily of receptor tyrosine kinases which are crucial formigration, repulsion and adhesion during neuronal, vascular andepithelial development. Binds promiscuously Eph receptors residingon adjacent cells, leading to contact-dependent bidirectionalsignaling into neighboring cells. Plays an important role inangiogenesis and tumor neovascularization. The recruitment ofVAV2, VAV3 and PI3-kinase p85 subunit by phosphorylated EPHA2 iscritical for EFNA1-induced RAC1 GTPase activation and vascularendothelial cell migration and assembly. Exerts anti-oncogeniceffects in tumor cells through activation and down-regulation ofEPHA2. Activates EPHA2 by inducing tyrosine phosphorylation whichleads to its internalization and degradation. Acts as a negativeregulator in the tumorigenesis of gliomas by down-regulating EPHA2and FAK. Can evoke collapse of embryonic neuronal growth cone andregulates dendritic spine morphogenesis.{ECO:0000269|PubMed:17332925, ECO:0000269|PubMed:18794797}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for PVT1_EFNA1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for PVT1_EFNA1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| PVT1 | TRIM25 | EFNA1 | PPBP, EEF1G, KAT5, EPHA4, EPHA3, XRCC6, GAREM |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for PVT1_EFNA1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for PVT1_EFNA1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | PVT1 | C0019829 | Hodgkin Disease | 1 | CTD_human |
| Hgene | PVT1 | C0162538 | Immunoglobulin A deficiency (disorder) | 1 | CTD_human |
| Tgene | EFNA1 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|